NEWS & MEDIA

Stay up to date with our latest news and upcoming events.

ivWatch Adopts Four Families For The Holidays

ivWatch is committed to improving the lives of others both in and outside of our office. We are proud of our team's dedication to giving back through the ivWatch Cares Program. ivWatch continued their annual holiday tradition to support Transitions Family Violence...

read more

ivWatch Announces Additional Global Distribution Partner

HAMPTON, VA, December 11, 2018 – ivWatch, the only provider of continuous patient monitoring devices for the early detection of intravenous (IV) infiltrations and extravasations, recently entered into a distribution agreement with Sedeer Medical Services. Sedeer...

read more

ivWatch Announces Two Senior Executives to Strengthen Growth

New roles include finance and research & development department leaders HAMPTON, Va., November 27, 2018 – ivWatch, a medical device and biosensor technology company specializing in continuous monitoring solutions for the early detection of intravenous (IV)...

read more

ivWatch Extends Patient Monitor to International Markets

HAMPTON, Va., November 14, 2018 – ivWatch, the only provider of continuous patient monitoring devices for the early detection of intravenous (IV) infiltrations and extravasations, announces a new international partner to manage distribution to support market expansion...

read more

In the News: Accelerating Device Acceptance

ivWatch CNO Talks Training Tips During Device Installations ivWatch Chief Nursing Officer, Susan Brown, offers insights on device implementation in the Medical Device and Diagnostic Industry (MD+DI) article, “Device Implementation Sets the Stage for Successful...

read more

ivWatch Continues to Expand Global Patent Portfolio

New European and Japanese grants bring total to seven owned patents  HAMPTON, Va., October 2, 2018 – ivWatch, the only provider of continuous monitoring devices for the early detection of intravenous (IV) infiltrations and extravasations, received two patents granted...

read more

ivWatch Receives CE Mark for the ivWatch Model 400

Recent regulatory approvals and global certification pave the way for international distribution  HAMPTON, Va., August 29, 2018 – ivWatch, the only provider of continuous monitoring devices for the early detection of intravenous (IV) infiltrations and extravasations,...

read more

For media inquiries, please contact:

Amara Betoney
ivWatch Manager, Public Relations
Direct: 757-224-2606
Office: 855-489-2824 ext. 7007
Mobile:757-660-4949
amara.betoney@ivwatch.com

ivWatch Logo White

Download Our Whitepaper

Thank you for requesting more information about the ivWatch Clinical Studies. The ivWatch Model 400 is the only continuous monitoring device for the early detection of IV infiltration and extravasation events.

[fc id='6'][/fc]

You have Successfully Subscribed!

Pin It on Pinterest